Stoke Therapeutics, Inc.
STOK
Cena:
$ 29.34
-0.33 (-1.11%)
Valuace
70
Růst
0
Zdraví
75
Akcionáři
Akcionáři společnosti
Insider trading
Akcionáři společnosti
| Držitel | Počet akcií | Podíl společnosti | Změna % | Váha pozice v portfoliu | Prvně nakoupeno |
|---|---|---|---|---|---|
| BLACKROCK INC. | 5.4 mil | 11.70% | 0.00% | 0.00% | 2019-06-30 |
| BLACKROCK FUNDING, INC. /DE | 5.9 mil | 10.45% | 0.00% | 0.00% | 2024-09-30 |
| RTW INVESTMENTS, LP | 5.6 mil | 9.50% | 0.06% | 1.82% | 2019-06-30 |
| BLACKROCK, INC. | 5.4 mil | 9.09% | 0.00% | 0.00% | 2024-09-30 |
| FMR LLC | 5.4 mil | 9.09% | 0.00% | 0.01% | 2019-06-30 |
| LYNX1 CAPITAL MANAGEMENT LP | 4.8 mil | 8.04% | -10.21% | 24.51% | 2023-09-30 |
| REDMILE GROUP, LLC | 4.2 mil | 7.03% | -0.45% | 8.98% | 2019-06-30 |
| MORGAN STANLEY | 3.4 mil | 5.78% | 0.00% | 0.01% | 2019-06-30 |
| COWEN AND COMPANY, LLC | 3.2 mil | 5.76% | 0.09% | 1.34% | 2021-09-30 |
| BAKER BROS. ADVISORS LP | 3.3 mil | 5.63% | 0.00% | 0.62% | 2022-09-30 |
| VANGUARD GROUP INC | 3.1 mil | 5.37% | 0.00% | 0.00% | 2019-06-30 |
| TORONTO DOMINION BANK | 3.2 mil | 5.36% | 0.00% | 0.15% | 2024-12-31 |
| WELLINGTON MANAGEMENT GROUP LLP | 3.1 mil | 5.23% | 0.01% | 0.02% | 2022-03-31 |
| BVF INC/IL | 2.5 mil | 4.30% | 0.22% | 2.64% | 2025-09-30 |
| SKORPIOS TRUST | 2.3 mil | 3.87% | 0.06% | 99.68% | 2021-12-31 |
| STATE STREET CORP | 2.3 mil | 3.84% | 0.00% | 0.00% | 2019-09-30 |
| SIREN, L.L.C. | 2.0 mil | 3.37% | -0.33% | 1.80% | 2024-12-31 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.9 mil | 3.27% | 0.01% | 0.01% | 2019-06-30 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1.8 mil | 3.08% | -0.04% | 0.70% | 2025-12-31 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 1.4 mil | 3.00% | 0.04% | 0.05% | 2021-09-30 |
| JANUS HENDERSON GROUP PLC | 1.6 mil | 2.72% | 0.00% | 0.03% | 2024-06-30 |
| LOGOS GLOBAL MANAGEMENT LP | 1.1 mil | 2.27% | 1.14% | 1.14% | 2024-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.3 mil | 2.23% | 0.00% | 0.00% | 2019-09-30 |
| POINT72 ASSET MANAGEMENT, L.P. | 1.2 mil | 2.09% | -0.01% | 0.04% | 2025-09-30 |
| POLAR CAPITAL HOLDINGS PLC | 1.1 mil | 1.91% | -0.02% | 0.13% | 2025-06-30 |
| DIMENSIONAL FUND ADVISORS LP | 989.94 tis | 1.67% | 0.00% | 0.01% | 2020-09-30 |
| ROYAL BANK OF CANADA | 915.79 tis | 1.57% | 0.00% | 0.00% | 2019-12-31 |
| ASSENAGON ASSET MANAGEMENT S.A. | 907.02 tis | 1.53% | -0.01% | 0.04% | 2024-06-30 |
| GOLDMAN SACHS GROUP INC | 830.70 tis | 1.40% | 0.00% | 0.00% | 2019-06-30 |
| MARSHALL WACE, LLP | 768.29 tis | 1.32% | -0.01% | 0.02% | 2023-09-30 |
| BIOIMPACT CAPITAL LLC | 767.04 tis | 1.30% | -0.87% | 1.93% | 2024-09-30 |
| OPALEYE MANAGEMENT INC. | 700.00 tis | 1.18% | 0.09% | 3.00% | 2024-12-31 |
| CI PRIVATE WEALTH, LLC | 659.83 tis | 1.13% | 0.01% | 0.01% | 2025-06-30 |
| TROLUCE CAPITAL ADVISORS LLC | 652.80 tis | 1.10% | 1.30% | 1.30% | 2026-03-31 |
| BAILLIE GIFFORD & CO | 575.18 tis | 0.97% | 0.01% | 0.02% | 2025-12-31 |
| BANK OF AMERICA CORP /DE/ | 543.10 tis | 0.92% | 0.00% | 0.00% | 2019-09-30 |
| CANDRIAM S.C.A. | 502.02 tis | 0.85% | 0.01% | 0.08% | 2025-12-31 |
| TANG CAPITAL MANAGEMENT LLC | 500.00 tis | 0.84% | 0.04% | 0.83% | 2024-12-31 |
| MILLENNIUM MANAGEMENT LLC | 472.14 tis | 0.80% | 0.01% | 0.01% | 2021-03-31 |
| 462.68 tis | 0.78% | 0.00% | 0.00% | 2026-03-31 | |
| ERSTE ASSET MANAGEMENT GMBH | 446.00 tis | 0.75% | 0.03% | 0.13% | 2025-03-31 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 437.18 tis | 0.74% | 0.00% | 0.00% | 2019-09-30 |
| NORTHERN TRUST CORP | 431.63 tis | 0.73% | 0.00% | 0.00% | 2019-09-30 |
| ARTAL GROUP S.A. | 300.00 tis | 0.65% | 0.10% | 0.10% | 2024-03-31 |
| DEUTSCHE BANK AG\ | 350.61 tis | 0.62% | 0.00% | 0.00% | 2019-09-30 |
| VANGUARD FIDUCIARY TRUST CO | 356.95 tis | 0.60% | 0.00% | 0.00% | 2026-03-31 |
| JANE STREET GROUP, LLC | 330.44 tis | 0.59% | 0.00% | 0.00% | 2023-12-31 |
| PARKMAN HEALTHCARE PARTNERS LLC | 336.52 tis | 0.57% | -0.17% | 1.13% | 2025-09-30 |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 335.59 tis | 0.57% | 0.27% | 0.53% | 2022-06-30 |
| NORGES BANK | 314.80 tis | 0.56% | 0.00% | 0.00% | 2024-12-31 |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 315.49 tis | 0.53% | 0.02% | 0.02% | 2026-03-31 |
| JPMORGAN CHASE & CO | 265.47 tis | 0.45% | 0.00% | 0.00% | 2019-09-30 |
| CORMORANT ASSET MANAGEMENT, LP | 254.16 tis | 0.44% | 0.09% | 0.21% | 2019-06-30 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 250.91 tis | 0.42% | 0.01% | 0.01% | 2026-03-31 |
| SCHONFELD STRATEGIC ADVISORS LLC | 238.02 tis | 0.41% | 0.02% | 0.03% | 2024-12-31 |
| SIO CAPITAL MANAGEMENT, LLC | 175.30 tis | 0.38% | -0.27% | 0.64% | 2024-03-31 |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 216.00 tis | 0.37% | -0.01% | 0.64% | 2025-09-30 |
| CHECKPOINT CAPITAL L.P. | 212.05 tis | 0.36% | 1.67% | 1.67% | 2024-09-30 |
| BIRCHVIEW CAPITAL, LP | 210.00 tis | 0.35% | -0.94% | 3.89% | 2020-03-31 |
| CAPTION MANAGEMENT, LLC | 200.00 tis | 0.34% | 0.04% | 0.04% | 2025-09-30 |
| RENAISSANCE TECHNOLOGIES LLC | 178.30 tis | 0.31% | 0.00% | 0.00% | 2024-03-31 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 141.52 tis | 0.31% | 0.45% | 0.45% | 2024-06-30 |
| D. E. SHAW & CO., INC. | 171.25 tis | 0.30% | 0.00% | 0.00% | 2022-09-30 |
| FIRST TRUST ADVISORS LP | 163.46 tis | 0.28% | 0.00% | 0.00% | 2025-09-30 |
| WALLEYE CAPITAL LLC | 126.83 tis | 0.27% | 0.00% | 0.00% | 2024-06-30 |
| UBS GROUP AG | 158.30 tis | 0.27% | 0.00% | 0.00% | 2021-03-31 |
| PENSERRA CAPITAL MANAGEMENT LLC | 150.60 tis | 0.26% | 0.04% | 0.04% | 2025-09-30 |
| BARCLAYS PLC | 150.95 tis | 0.26% | 0.00% | 0.00% | 2019-06-30 |
| INVESCO LTD. | 150.05 tis | 0.25% | 0.00% | 0.00% | 2024-06-30 |
| BANK OF NEW YORK MELLON CORP | 143.41 tis | 0.24% | 0.00% | 0.00% | 2019-09-30 |
| FRANKLIN RESOURCES INC | 142.79 tis | 0.24% | 0.00% | 0.00% | 2024-03-31 |
| DAFNA CAPITAL MANAGEMENT LLC | 130.88 tis | 0.22% | 0.17% | 0.97% | 2024-03-31 |
| LAURION CAPITAL MANAGEMENT LP | 100.00 tis | 0.22% | 0.01% | 0.01% | 2024-03-31 |
| MAVEN SECURITIES LTD | 100.00 tis | 0.22% | 0.08% | 0.08% | 2024-03-31 |
| SQUAREPOINT OPS LLC | 120.24 tis | 0.21% | 0.00% | 0.00% | 2023-03-31 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 123.48 tis | 0.21% | 0.00% | 0.01% | 2025-03-31 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 97.80 tis | 0.21% | 0.00% | 0.00% | 2023-12-31 |
| GSA CAPITAL PARTNERS LLP | 97.51 tis | 0.21% | 0.06% | 0.10% | 2021-09-30 |
| CITADEL ADVISORS LLC | 123.02 tis | 0.21% | 0.00% | 0.00% | 2024-09-30 |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 119.23 tis | 0.20% | 0.00% | 0.06% | 2025-03-31 |
| EAM INVESTORS, LLC | 117.82 tis | 0.20% | 0.10% | 0.42% | 2025-09-30 |
| EXOME ASSET MANAGEMENT LLC | 113.10 tis | 0.20% | -0.53% | 0.94% | 2024-09-30 |
| HIGHVISTA STRATEGIES LLC | 115.54 tis | 0.20% | 0.94% | 0.94% | 2025-12-31 |
| AMERICAN CENTURY COMPANIES INC | 115.12 tis | 0.20% | 0.00% | 0.00% | 2025-06-30 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 90.66 tis | 0.20% | 0.00% | 0.00% | 2022-06-30 |
| NUVEEN ASSET MANAGEMENT, LLC | 108.09 tis | 0.19% | 0.00% | 0.00% | 2019-09-30 |
| GILDER GAGNON HOWE & CO LLC | 112.63 tis | 0.19% | 0.00% | 0.04% | 2019-06-30 |
| GROUP ONE TRADING, L.P. | 104.41 tis | 0.19% | 0.00% | 0.00% | 2024-09-30 |
| PANAGORA ASSET MANAGEMENT INC | 104.27 tis | 0.19% | 0.01% | 0.01% | 2024-12-31 |
| UBS ASSET MANAGEMENT AMERICAS INC | 107.24 tis | 0.18% | 0.00% | 0.00% | 2024-06-30 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 103.01 tis | 0.18% | 0.00% | 0.01% | 2021-06-30 |
| PALO ALTO INVESTORS LP | 105.43 tis | 0.18% | 0.15% | 0.46% | 2024-03-31 |
| NUVEEN, LLC | 104.26 tis | 0.18% | 0.00% | 0.00% | 2025-03-31 |
| ELEMENT CAPITAL MANAGEMENT LLC | 96.38 tis | 0.17% | 0.05% | 0.05% | 2024-09-30 |
| WOODLINE PARTNERS LP | 95.12 tis | 0.16% | 0.00% | 0.01% | 2023-03-31 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 86.89 tis | 0.15% | 0.00% | 0.00% | 2024-06-30 |
| TREXQUANT INVESTMENT LP | 86.14 tis | 0.15% | -0.01% | 0.01% | 2021-03-31 |
| SG AMERICAS SECURITIES, LLC | 68.60 tis | 0.15% | 0.00% | 0.01% | 2023-09-30 |
| MONASHEE INVESTMENT MANAGEMENT LLC | 67.58 tis | 0.15% | 0.11% | 0.11% | 2024-03-31 |
| AQR CAPITAL MANAGEMENT LLC | 75.09 tis | 0.13% | 0.00% | 0.00% | 2024-09-30 |
| FORT POINT CAPITAL PARTNERS LLC | 75.43 tis | 0.13% | 0.01% | 0.06% | 2021-12-31 |
| CITIGROUP INC | 74.62 tis | 0.13% | 0.00% | 0.00% | 2019-09-30 |
| RHUMBLINE ADVISERS | 66.42 tis | 0.11% | 0.00% | 0.00% | 2019-12-31 |
| LMR PARTNERS LLP | 50.00 tis | 0.11% | 0.01% | 0.01% | 2024-03-31 |
| SWISS NATIONAL BANK | 62.00 tis | 0.11% | 0.00% | 0.00% | 2024-06-30 |
| KENNONDALE CAPITAL MANAGEMENT LLC | 61.18 tis | 0.10% | 0.40% | 0.71% | 2025-03-31 |
| TWO SIGMA INVESTMENTS, LP | 53.95 tis | 0.10% | 0.00% | 0.00% | 2020-12-31 |
| GTS SECURITIES LLC | 41.60 tis | 0.09% | 0.00% | 0.00% | 2024-03-31 |
| EVERSEPT PARTNERS, LP | 52.01 tis | 0.09% | -0.01% | 0.04% | 2024-03-31 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 53.41 tis | 0.09% | 0.00% | 0.00% | 2024-06-30 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 49.90 tis | 0.09% | 0.04% | 0.04% | 2024-09-30 |
| RAFFERTY ASSET MANAGEMENT, LLC | 51.46 tis | 0.09% | 0.00% | 0.00% | 2024-06-30 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 51.24 tis | 0.09% | 0.00% | 0.00% | 2023-03-31 |
| LEGAL & GENERAL GROUP PLC | 36.47 tis | 0.08% | 0.00% | 0.00% | 2019-09-30 |
| ALLIANCEBERNSTEIN L.P. | 40.63 tis | 0.07% | 0.00% | 0.00% | 2020-03-31 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 33.09 tis | 0.07% | 0.00% | 0.00% | 2019-09-30 |
| STATE OF WISCONSIN INVESTMENT BOARD | 39.11 tis | 0.07% | 0.00% | 0.00% | 2019-09-30 |
| SEVEN GRAND MANAGERS, LLC | 30.00 tis | 0.07% | 0.20% | 0.20% | 2024-03-31 |
| GHISALLO CAPITAL MANAGEMENT LLC | 30.00 tis | 0.07% | 0.05% | 0.05% | 2024-03-31 |
| BELVEDERE TRADING LLC | 23.67 tis | 0.05% | 0.00% | 0.00% | 2024-03-31 |
| PDT PARTNERS, LLC | 21.43 tis | 0.05% | 0.03% | 0.03% | 2024-03-31 |
| CHASE INVESTMENT COUNSEL CORP | 20.74 tis | 0.05% | 0.10% | 0.10% | 2024-03-31 |
| METLIFE INVESTMENT MANAGEMENT, LLC | 20.81 tis | 0.05% | 0.00% | 0.00% | 2019-12-31 |
| TUDOR INVESTMENT CORP ET AL | 18.40 tis | 0.04% | 0.00% | 0.00% | 2021-12-31 |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | 17.28 tis | 0.04% | 0.00% | 0.00% | 2023-09-30 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 17.10 tis | 0.04% | 0.00% | 0.00% | 2023-12-31 |
| MAN GROUP PLC | 15.36 tis | 0.03% | 0.00% | 0.00% | 2022-09-30 |
| PROFUND ADVISORS LLC | 14.89 tis | 0.03% | 0.01% | 0.01% | 2024-06-30 |
| ZACKS INVESTMENT MANAGEMENT | 14.06 tis | 0.03% | 0.00% | 0.00% | 2023-12-31 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 13.96 tis | 0.03% | 0.00% | 0.00% | 2020-03-31 |
| VOYA INVESTMENT MANAGEMENT LLC | 11.93 tis | 0.03% | 0.00% | 0.00% | 2023-06-30 |
| WELLS FARGO & COMPANY/MN | 11.39 tis | 0.02% | 0.00% | 0.00% | 2019-09-30 |
| DORSEY & WHITNEY TRUST CO LLC | 10.82 tis | 0.02% | 0.00% | 0.01% | 2023-09-30 |
| NEW YORK STATE COMMON RETIREMENT FUND | 10.64 tis | 0.02% | 0.00% | 0.00% | 2019-09-30 |
| AMERIPRISE FINANCIAL INC | 10.31 tis | 0.02% | 0.00% | 0.00% | 2023-09-30 |
Insider trading
| Jméno | Pozice | Typ transakce | Počet převedených akcií | Průměrná cena akcie | Datum | Počet držených akcií |
|---|---|---|---|---|---|---|
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | S-Sale | 2243 | 32.79 | 5.5 2026 | 36621 |
| Kahn Clare | 0 | 0.00 | 7.4 2026 | 0 | ||
| Kahn Clare | director | A-Award | 30782 | 32.79 | 7.4 2026 | 30782 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | S-Sale | 1838 | 32.66 | 3.4 2026 | 38864 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | S-Sale | 601 | 34.41 | 24.3 2026 | 19543 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | S-Sale | 8692 | 33.64 | 24.3 2026 | 20144 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | S-Sale | 72 | 32.85 | 19.3 2026 | 28836 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | S-Sale | 334 | 31.79 | 19.3 2026 | 28908 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | S-Sale | 4222 | 31.28 | 19.3 2026 | 29242 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | S-Sale | 1791 | 33.38 | 19.3 2026 | 33464 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | S-Sale | 2476 | 32.74 | 19.3 2026 | 35255 |
| Hoitt Jason | officer: Chief Patient Officer | S-Sale | 30 | 32.85 | 19.3 2026 | 10276 |
| Hoitt Jason | officer: Chief Patient Officer | S-Sale | 139 | 31.79 | 19.3 2026 | 10306 |
| Hoitt Jason | officer: Chief Patient Officer | S-Sale | 1762 | 31.28 | 19.3 2026 | 10445 |
| Hoitt Jason | officer: Chief Patient Officer | S-Sale | 748 | 33.38 | 19.3 2026 | 12207 |
| Hoitt Jason | officer: Chief Patient Officer | S-Sale | 1033 | 32.74 | 19.3 2026 | 12955 |
| Leggett Thomas | officer: Chief Financial Officer | S-Sale | 37 | 32.85 | 19.3 2026 | 10172 |
| Leggett Thomas | officer: Chief Financial Officer | S-Sale | 172 | 31.79 | 19.3 2026 | 10209 |
| Leggett Thomas | officer: Chief Financial Officer | S-Sale | 2173 | 31.28 | 19.3 2026 | 10381 |
| Leggett Thomas | officer: Chief Financial Officer | S-Sale | 922 | 33.38 | 19.3 2026 | 12554 |
| Leggett Thomas | officer: Chief Financial Officer | S-Sale | 1274 | 32.74 | 19.3 2026 | 13476 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | S-Sale | 1461 | 29.99 | 19.3 2026 | 40702 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | S-Sale | 103 | 32.85 | 19.3 2026 | 40798 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | S-Sale | 483 | 31.79 | 19.3 2026 | 40901 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | S-Sale | 6100 | 31.28 | 19.3 2026 | 41384 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | M-Exempt | 1365 | 2.19 | 19.3 2026 | 42163 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | S-Sale | 2587 | 33.38 | 19.3 2026 | 47484 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | S-Sale | 3577 | 32.74 | 19.3 2026 | 50071 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | M-Exempt | 1365 | 2.19 | 19.3 2026 | 83035 |
| LEVIN ARTHUR A | director | S-Sale | 605 | 36.80 | 17.3 2026 | 4237 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | M-Exempt | 7475 | 0.00 | 17.3 2026 | 7475 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | M-Exempt | 6000 | 0.00 | 17.3 2026 | 12000 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | M-Exempt | 7475 | 0.00 | 17.3 2026 | 19731 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | M-Exempt | 6000 | 0.00 | 17.3 2026 | 25731 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | M-Exempt | 12000 | 0.00 | 17.3 2026 | 36000 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | M-Exempt | 12000 | 0.00 | 17.3 2026 | 37731 |
| Kaye Edward M. MD | director | M-Exempt | 35500 | 0.00 | 17.3 2026 | 35500 |
| Kaye Edward M. MD | director | M-Exempt | 26250 | 0.00 | 17.3 2026 | 52500 |
| Kaye Edward M. MD | director | M-Exempt | 35500 | 0.00 | 17.3 2026 | 84624 |
| Kaye Edward M. MD | director | M-Exempt | 26250 | 0.00 | 17.3 2026 | 110874 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | M-Exempt | 13100 | 0.00 | 17.3 2026 | 13100 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | M-Exempt | 10000 | 0.00 | 17.3 2026 | 20000 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | M-Exempt | 10750 | 0.00 | 17.3 2026 | 32250 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | M-Exempt | 13100 | 0.00 | 17.3 2026 | 32898 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | M-Exempt | 10000 | 0.00 | 17.3 2026 | 42898 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | M-Exempt | 10750 | 0.00 | 17.3 2026 | 53648 |
| Leggett Thomas | officer: Chief Financial Officer | M-Exempt | 14750 | 0.00 | 17.3 2026 | 14750 |
| Leggett Thomas | officer: Chief Financial Officer | M-Exempt | 14750 | 0.00 | 17.3 2026 | 44250 |
| Hoitt Jason | officer: Chief Patient Officer | M-Exempt | 10000 | 0.00 | 17.3 2026 | 13988 |
| Hoitt Jason | officer: Chief Patient Officer | M-Exempt | 10000 | 0.00 | 17.3 2026 | 30000 |
| Krainer Adrian R. | director | S-Sale | 33243 | 39.74 | 12.3 2026 | 283302 |
| TZIANABOS ARTHUR | director, officer: Interim Executive Chair | S-Sale | 4355 | 40.00 | 12.3 2026 | 31339 |
| TZIANABOS ARTHUR | director, officer: Interim Executive Chair | M-Exempt | 3955 | 8.33 | 12.3 2026 | 35694 |
| TZIANABOS ARTHUR | director, officer: Interim Executive Chair | M-Exempt | 3955 | 8.33 | 12.3 2026 | 118696 |
| Krainer Adrian R. | director | S-Sale | 7229 | 39.66 | 4.3 2026 | 316545 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | A-Award | 35000 | 0.00 | 19.2 2026 | 35000 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | A-Award | 53000 | 31.09 | 19.2 2026 | 53000 |
| Hoitt Jason | officer: Chief Patient Officer | A-Award | 48000 | 0.00 | 19.2 2026 | 48000 |
| Hoitt Jason | officer: Chief Patient Officer | A-Award | 72000 | 31.09 | 19.2 2026 | 72000 |
| Leggett Thomas | officer: Chief Financial Officer | A-Award | 40000 | 0.00 | 19.2 2026 | 40000 |
| Leggett Thomas | officer: Chief Financial Officer | A-Award | 60000 | 31.09 | 19.2 2026 | 60000 |
| SMITH IAN F | director, officer: Chief Executive Officer | A-Award | 129000 | 0.00 | 19.2 2026 | 129000 |
| SMITH IAN F | director, officer: Chief Executive Officer | A-Award | 193000 | 31.09 | 19.2 2026 | 193000 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | A-Award | 40000 | 0.00 | 19.2 2026 | 40000 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | A-Award | 60000 | 31.09 | 19.2 2026 | 60000 |
| LEVIN ARTHUR A | director | M-Exempt | 1211 | 0.00 | 5.1 2026 | 0 |
| LEVIN ARTHUR A | director | M-Exempt | 1211 | 0.00 | 5.1 2026 | 4842 |
| Kaye Edward M. MD | director | S-Sale | 1331 | 33.10 | 10.12 2025 | 49124 |
| Kaye Edward M. MD | director | S-Sale | 8274 | 32.52 | 10.12 2025 | 50455 |
| Kaye Edward M. MD | director | S-Sale | 3825 | 31.44 | 10.12 2025 | 58729 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | S-Sale | 2678 | 32.61 | 10.12 2025 | 11831 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | S-Sale | 1300 | 31.60 | 10.12 2025 | 14509 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | M-Exempt | 6000 | 0.00 | 5.12 2025 | 0 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | S-Sale | 2344 | 31.76 | 5.12 2025 | 15809 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | S-Sale | 5437 | 31.08 | 5.12 2025 | 18153 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | S-Sale | 1004 | 31.33 | 5.12 2025 | 23590 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | S-Sale | 194 | 31.32 | 5.12 2025 | 24594 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | S-Sale | 824 | 30.76 | 5.12 2025 | 24788 |
| Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | M-Exempt | 6000 | 0.00 | 5.12 2025 | 25612 |
| Kaye Edward M. MD | director | M-Exempt | 26250 | 0.00 | 5.12 2025 | 0 |
| Kaye Edward M. MD | director | S-Sale | 500 | 31.85 | 5.12 2025 | 62554 |
| Kaye Edward M. MD | director | S-Sale | 1681 | 31.15 | 5.12 2025 | 63054 |
| Kaye Edward M. MD | director | S-Sale | 6367 | 31.33 | 5.12 2025 | 64735 |
| Kaye Edward M. MD | director | S-Sale | 1231 | 31.32 | 5.12 2025 | 71102 |
| Kaye Edward M. MD | director | S-Sale | 5222 | 30.76 | 5.12 2025 | 72333 |
| Kaye Edward M. MD | director | M-Exempt | 26250 | 0.00 | 5.12 2025 | 77555 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | M-Exempt | 10000 | 0.00 | 5.12 2025 | 0 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | S-Sale | 1989 | 31.35 | 5.12 2025 | 19798 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | S-Sale | 1673 | 31.33 | 5.12 2025 | 21787 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | S-Sale | 323 | 31.32 | 5.12 2025 | 23460 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | S-Sale | 1373 | 30.76 | 5.12 2025 | 23783 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | M-Exempt | 10000 | 0.00 | 5.12 2025 | 25156 |
| Kaye Edward M. MD | director | S-Sale | 661 | 29.56 | 3.12 2025 | 52780 |
| Kaye Edward M. MD | director | M-Exempt | 4317 | 0.00 | 3.12 2025 | 53441 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | M-Exempt | 11981 | 0.00 | 3.12 2025 | 0 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | S-Sale | 1225 | 30.85 | 3.12 2025 | 15156 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | S-Sale | 789 | 30.34 | 3.12 2025 | 16381 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | S-Sale | 762 | 30.14 | 3.12 2025 | 17170 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | S-Sale | 1244 | 29.56 | 3.12 2025 | 17932 |
| Ticho Barry | officer: CHIEF MEDICAL OFFICER | M-Exempt | 11981 | 0.00 | 3.12 2025 | 19176 |
